Company: BDRX
Filing Date: 2025-11-17
Form Type: F-1
Source: 0001214659-25-016821
Chunk: 31

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: F-1
Chunk 31
---
 consummation of the Fundamental Transaction to require us to repurchase the warrant for a purchase price in cash equal to the Black
Scholes value (as calculated under the warrant agreement) of the then remaining unexercised portion of such warrant on the date of such
Fundamental Transaction, which may materially adversely affect our financial condition and/or results of operations and may prevent or
deter a third party from acquiring us.

| 19 |

<div align='center'>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

This prospectus contains forward-looking
statements that are based on our management’s beliefs and assumptions and on information currently available. This section should
be read in conjunction with our financial statements and related notes incorporated by reference into this prospectus. The statements
contained in this prospectus that are not historical facts are forward-looking statements within the meaning of Section 27A of the
Securities Act and Section 21E of the Exchange Act.

Forward-looking statements
can be identified by words such as “believe,” “anticipate,” “may,” “might,” “can,”
“could,” “continue,” “depends,” “expect,” “expand,” “forecast,”
“intend,” “predict,” “plan,” “rely,” “should,” “will,” “may,”
“seek,” or the negative of these terms and other similar expressions, although not all forward-looking statements contain
these words. You should read these statements carefully because they discuss future expectations, contain projections of future results
of operations or financial condition, or state other “forward-looking” information. These statements relate to our future
plans, objectives, expectations, intentions and financial performance and the assumptions that underlie these statements.

These forward-looking statements
are subject to a number of risks, uncertainties, and assumptions, including, but not limited to, those described in “Risk Factors.”
These forward-looking statements reflect our beliefs and views with respect to future events and are based on estimates and assumptions
as of the date of this prospectus and are subject to risks and uncertainties. We discuss many of these risks in greater detail in the
section titled “Risk Factors” and elsewhere in this prospectus. Given these uncertainties, you should not place undue
reliance on these forward-looking statements. We qualify all of the forward-looking statements in this prospectus by these cautionary
statements. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons